EUVIMEDObjevte EUVIMED
Crossref

Evaluation of the Antidepressant Potential of Triplochiton scleroxylon Leaf Extract Using Tail Suspension and Forced Swim Tests

Albashir Tahir, Khadija Abdullahi Kobi, Abbas Nasidi, Nura Bello

Recent Trends in Pharmacology · 2026-04-24 · 4 (1) · 18-23

DOI: 10.62425/rtpharma.1897763 ↗

At a glance

Journal article in Recent Trends in Pharmacology, published online on 2026-04-24. Written by Albashir Tahir and 3 co-authors. 24 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Depression is a major neuropsychiatric disorder with a substantial global burden. Existing pharmacotherapies are limited by delayed onset of action, incomplete response, and adverse effects, necessitating the exploration of alternative therapeutic agents, particularly from medicinal plants. Triplochiton scleroxylon was selected based on its ethnomedicinal use and reported richness in bioactive phytochemicals with potential neuropharmacological activity. This study evaluated the antidepressant-like activity, phytochemical composition, and acute toxicity profile of the ethanol leaf extract of T. scleroxylon in murine models.

Methods

Fresh leaves of T. scleroxylon were extracted by ethanol maceration, yielding 14.4% crude extract. Preliminary phytochemical screening was conducted using standard qualitative methods. Acute toxicity was assessed using Lorke’s method. Antidepressant-like activity was evaluated in mice (n=4 per group) using the Tail Suspension Test (TST) and Forced Swim Test (FST). Animals received oral doses of 22.5, 45, and 90 mg/kg extract, with imipramine (10 mg/kg) as the reference drug.

Results

Phytochemical analysis revealed the presence of flavonoids, alkaloids, tannins, saponins, and steroids. No mortality was observed at 10 and 100 mg/kg in the acute toxicity study, while mortality occurred at 1000 mg/kg. In both TST and FST models, the extract significantly reduced immobility time at 45 and 90 mg/kg in a dose-dependent manner (p

Cite

APA

Tahir, A., Kobi, K. A., Nasidi, A., & Bello, N. (2026). Evaluation of the Antidepressant Potential of Triplochiton scleroxylon Leaf Extract Using Tail Suspension and Forced Swim Tests. Recent Trends in Pharmacology, 4(1), 18-23. https://doi.org/10.62425/rtpharma.1897763

Vancouver

Tahir A, Kobi KA, Nasidi A, Bello N. Evaluation of the Antidepressant Potential of Triplochiton scleroxylon Leaf Extract Using Tail Suspension and Forced Swim Tests. Recent Trends in Pharmacology. 2026;4(1):18-23. doi:10.62425/rtpharma.1897763

BibTeX
@article{Tahir2026,
  author = {Tahir, Albashir and Kobi, Khadija Abdullahi and Nasidi, Abbas and Bello, Nura},
  title = {Evaluation of the Antidepressant Potential of Triplochiton scleroxylon Leaf Extract Using Tail Suspension and Forced Swim Tests},
  journal = {Recent Trends in Pharmacology},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {18--23},
  doi = {10.62425/rtpharma.1897763}
}
Start for free →